Chanelle Pharma is Ireland’s largest manufacturer of generic pharmaceuticals for human and animal health. Chanelle Pharma employs more than 700 people in Ireland, the UK, Portugal and Jordan. Headquartered in Loughrea Ireland, its four manufacturing and five R&D facilities all operate to the highest regulatory standards. Its global supply chain and distribution network exports to over 80 countries. In February 2024, Chanelle Pharma was acquired by Exponent PE, a leading European private equity firm.
For further information please visit www.chanellepharma.com
